selected publications
- 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis & rheumatology (Hoboken, N.J.). 2022 Academic Article GET IT
- 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis care & research. 2022 Academic Article GET IT
- 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. The Journal of arthroplasty. 2022 Academic Article GET IT
-
Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.
JCI insight.
2020
Academic Article
GET IT
Times cited: 14 -
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
The oncologist.
2019
Review
GET IT
Times cited: 40 -
CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus.
Lancet (London, England).
2018
Article
GET IT
Times cited: 7 -
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.
Science translational medicine.
2018
Academic Article
GET IT
Times cited: 81 -
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Arthritis & rheumatology (Hoboken, N.J.).
2016
Academic Article
GET IT
Times cited: 107 -
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Annals of the rheumatic diseases.
2013
Academic Article
GET IT
Times cited: 134 -
The proto-oncogene c-myc regulates antibody secretion and Ig class switch recombination.
Journal of immunology (Baltimore, Md. : 1950).
2013
Academic Article
GET IT
Times cited: 9 -
One size does not fit all: on how Markov model order dictates performance of genomic sequence analyses.
Nucleic acids research.
2012
Academic Article
GET IT
Times cited: 24 -
The role of the proto-oncogene c-myc in B lymphocyte differentiation.
Critical reviews in immunology.
2012
Information Resource
GET IT
Times cited: 3 -
B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.
Journal of immunology (Baltimore, Md. : 1950).
2011
Academic Article
GET IT
Times cited: 21 -
Endogenous retroviral pathogenesis in lupus.
Current opinion in rheumatology.
2010
Information Resource
GET IT
Times cited: 64 -
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
Arthritis research & therapy.
2010
Information Resource
GET IT
Times cited: 129 -
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?.
Discovery medicine.
2010
Information Resource
GET IT
Times cited: 110 -
T-cell and B-cell signaling biomarkers and treatment targets in lupus.
Current opinion in rheumatology.
2009
Information Resource
GET IT
Times cited: 40 -
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
The Journal of clinical investigation.
2009
Academic Article
GET IT
Times cited: 72 -
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
Journal of immunology (Baltimore, Md. : 1950).
2009
Academic Article
GET IT
Times cited: 225 -
Reduced calmodulin expression accelerates transient outward potassium current inactivation in diabetic rat heart.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
2008
Academic Article
GET IT
Times cited: 10 -
Metabolic control of T cell activation and death in SLE.
Autoimmunity reviews.
2008
Information Resource
GET IT
Times cited: 91 -
Structural basis for ether-a-go-go-related gene K+ channel subtype-dependent activation by niflumic acid.
Molecular pharmacology.
2008
Academic Article
GET IT
Times cited: 19 -
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.
Cancer genetics and cytogenetics.
2007
Academic Article
GET IT
Times cited: 13 -
Nitric oxide, mitochondrial hyperpolarization, and T cell activation.
Free radical biology & medicine.
2007
Information Resource
GET IT
Times cited: 60 -
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
Arthritis and rheumatism.
2006
Academic Article
GET IT
Times cited: 282 -
Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
The Journal of biological chemistry.
2006
Academic Article
GET IT
Times cited: 54 -
Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels.
Journal of cardiovascular pharmacology.
2006
Academic Article
GET IT
Times cited: 34 -
Molecular mapping of a site for Cd2+-induced modification of human ether-à-go-go-related gene (hERG) channel activation.
The Journal of physiology.
2005
Academic Article
GET IT
Times cited: 26 -
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
Carcinogenesis.
2005
Academic Article
GET IT
Times cited: 94 -
Pyroglutamyl peptidase I and prolyl endopeptidase in human semen: increased activity in necrozoospermia.
Regulatory peptides.
2004
Academic Article
GET IT
Times cited: 17 -
Enkephalin-degrading enzymes in normal and subfertile human semen.
Journal of andrology.
2004
Academic Article
GET IT
Times cited: 34 -
interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
Cancer research.
2004
Academic Article
GET IT
Times cited: 56